Market Overview
ASX 200 Index
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
Uranium Needs to be Discussed: Big tech demand meets structural deficit
Uranium rally as AI data centers and SMRs power multi-million tech PPAs; looming structural deficit puts uranium in focus for investors.
How 'Balanced' Is Your Super?
No standard for 'balanced' super funds in Australia; risk and returns vary widely. Check your asset mix before retirement.
The Weekly Finger: On bruised legs and bruised portfolios
Oil surges; crude ETF jumps 33% in a week—the biggest weekly gain on record—plus a new Finger on the Pulse episode and a revamped Investor Pulse site.
Weekly Wrap: A record close and 3.7% month a big thumbs up
ASX 200 finishes at record close, up 3.7% in Feb as BHP profits beat and banks top forecasts; Block rockets on staff cuts; rare-earths rally lifts Lynas/Iluka.
Boss Energy Reports $36.2m Positive Net Cash Flow from Honeymoon Uranium Project
Boss Energy (ASX: BOE) logs $36.2m positive net cash flow from Honeymoon uranium project; six months to Dec lift in uranium sales, lower C1 costs boost outlook.
Weekly Wrap: ASX slips on war fears as earnings beat expectations buoy week
War fears nudge ASX 200 lower despite QBE's 21% profit surge; energy gains lift oil names, tech slumps; Guzman sinks below float.
ANZ Soars and AMP Sinks: Earnings Breakdown
ANZ delivers $1.9b cash profit in Q1, 3bp NIM uplift, and cost discipline driving outperformance as Feb earnings season kicks off (AMP results due).
Syrah Resources Left to Navigate US ITC's Negative AD/CVD Ruling on Chinese Graphite Imports
Syrah Resources avoids US AD/CVD tariffs after ITC's negative ruling on Chinese graphite; Vidalia AAM sales may be delayed despite ready capacity.
Everest Metals Eyes Near-Term Production After Bonanza Gold Grades at Mt Dimer Taipan
Everest Metals eyes near-term production after bonanza-grade RC results at Mt Dimer Taipan, with 45,000t ROM and April 2026 processing.
Felix Gold Reports High-Grade Antimony Extensions at Treasure Creek in Alaska
Felix Gold expands high-grade antimony at Treasure Creek, Alaska, with shallow intercepts up to 12.53% Sb and a gold halo, boosting US supply potential.
Aguia Resources Targets May Production After Securing Key Concession for Tres Estradas Phosphate Project
Aguia Resources secures Tres Estradas concession, targeting May 2026 production; Pampafos launch underway as Colombian gold ops improve.
Immutep Discontinues TACTI-004 Phase III Trial Due to Futility
Immutep halts TACTI-004 Phase III in first-line NSCLC due to futility; shares resume trading as cash runway extends beyond Q2 CY2027.
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.
Patrys Advances RLS-2201 Program with Manufacturing Start and FDA Regulatory Engagement
Patrys kicks off RLS-2201 manufacturing with BioCina and FDA 505(b)(2) engagement, targeting Phase 0 trials in H2 2026.
Dimerix Completes Adult Dosing for ACTION3 DMX-200 Trial
Dimerix completes adult dosing for ACTION3 DMX-200 in FSGS; 333 patients vs 286 target, boosting statistical power and de-risking regulatory submission.
DorsaVi Advances Edge AI and Robotics Strategy with 22nm RRAM Tests
DorsaVi kicks off 180-nm RRAM testing as it targets a 22-nm edge AI/robotics platform, boosting neuromorphic ambitions amid FY25 revenue decline.
InteliCare Signs $8.8m Deal to Deploy Aged Care Technology Platform into Victorian Residential Facilities
InteliCare inks $8.8m 5-year deal to roll out its predictive analytics IoT platform across mecwacare's Victorian facilities, largest contract yet.
RocketDNA Launches Testing Phase of Skylink Software Platform with Global Mining Customer
RocketDNA (ASX: RKT) launches Skylink testing phase with Tier-1 mining client, delivering real-time drone data and on-demand missions at scale.
BluGlass Lands A$1.25M Defence Program With US Tier-1 Prime Customer
BluGlass lands A$1.25m GaN laser defence program with US Tier-1 prime; initial A$560k order, 14–20 month milestones, boosts US footprint.
Forte Energy Completes Acquisition of Large Oil Lease Position in Alaska
Forte Energy clinches 143,368-acre Alaska NPR-A lease position; 2026 suspension cuts ~$430k fees, fueling farmouts as Harrier targets >1B barrels.
NH3 Commences Flora and Vegetation Surveys After Receiving FEED Proposals for WAH2 Clean Ammonia Project
NH3 Clean Energy (ASX: NH3) hits FEED bids for WAH2 clean ammonia; flora survey underway as it targets FEED mid-year and FID by year-end, production 2H 2029.
Amplitude Energy Commences Gas Flow Testing at Isabella Prospect
Amplitude Energy kicks off Isabella flow testing after ST-1 gas hit; two weeks to prove commercial viability, shaping ECSP progress and EnergyAustralia GSA.
Vintage Energy Extends PURE Loan Facility to Support Southern Flank Reinvigoration
Vintage Energy extends $10m PURE loan to Jan 2028, enabling Odin-3 and Vali-4 drilling with $5m SA grant; potential early $3m repayment, cash covenant eased.
Titomic Plans US Redomicile to Boost Defense Market Access and Pursue US Listing
Titomic to redomicile in the US to boost defense/aerospace market access, pursuing a US listing in H2 2026; approvals including Federal Court clearance pending.
Southern Cross Electrical Lifts FY26 EBITDA Guidance Despite H1 NPAT Loss
SXE lifts FY26 EBITDA guidance to at least $72m despite H1 NPAT loss of $12.8m from WestConnex costs; cash-rich, no debt, expanding data-centre pipeline.
The Calmer Co Subsidiary Wins $354,000 Grant to Upgrade Fiji Kava Manufacturing Facility
The Calmer Co International subsidiary wins $354k Fiji CADP grant to upgrade Navua kava RTD bottling, boost Pacific supply chain and expand production.
Pure Foods Tasmania Sees Positive Cash Flow and Increased Profit Margins After Business Realignment
ASX: PFT Pure Foods Tasmania posts positive cash flow and rising margins after realignment, with 70% higher Easter orders and expanding retail reach.
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]
Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]
ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]